Biography

Dr Fayyaz Ahmed is a Consultant Neurologist and Hon. Senior Lecturer at Hull University Teaching Hospitals NHS Trust and Hull York Medical School. Dr Ahmed graduated from Dow Medical College Karachi, Pakistan in 1986.  He moved on to the UK after his residency and received his neurology training at St James’s University Hospital, Leeds and Imperial College London.  He did his research on cerebral blood flow in migraine and clinical training in headache at the Princess Margaret Migraine Clinic, Charing Cross Hospital, London.  He was appointed as Consultant Neurologist in Hull in 1996 where he established a dedicated headache clinic. He did his MBA in Public Sector Management from University of Hull in 2010 and a post-graduate certificate in medical education (PGCME) in 2015 and is currently the Educational Officer of the British Association for the Study of Headache having served as a Secretary (2005-2008), Vice Chair (2009-2010) and Chair (2011-2013). He is a Trustee of the International Headache Society and Migraine Trust, Chair of Anglo-Dutch Migraine Association (ADMA), member of Headache advisory group at the Association of British Neurologist and Director of Migraine Trust International Symposium (MTIS). He is a former Chair of Headache UK and Director of the European Headache and Migraine Trust International Congress (EHMTIC). He served on NICE in the development of Headache Guideline (CG150) and has co-authored the current BASH guidelines 2019.

Disclosures

Employment: Hull University Teaching Hospital

Society Leadership/Board position: Treasurer Anglo Dutch Migraine Association; Council member BASH; Chair Scientific Committee Migraine Trust

Professional membership: British Association for the Study of Headache; Anglo-Dutch Migraine Association

Personal fees: Allergan; Abbvie; Novartis; Lundbeck; Eli Lilly; Teva; Pfizer

Clinical trials involvement: Chordate; Abbvie; Matsui; Pfizer; Amgen; Lundbeck; Teva

Relationship with scientific journals: Cephalalgia; Journal of Headache and Pain; Practical Neurology; ACNR

Commercial interests: None